AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $5,305,000 | -63.3% | 707,398 | -55.5% | 0.18% | -49.6% |
Q1 2022 | $14,459,000 | +66.3% | 1,588,944 | +28.3% | 0.36% | +100.6% |
Q4 2021 | $8,697,000 | -45.3% | 1,238,883 | -11.1% | 0.18% | -40.7% |
Q3 2021 | $15,895,000 | -28.5% | 1,394,270 | +0.5% | 0.30% | -27.1% |
Q2 2021 | $22,221,000 | +7.3% | 1,387,971 | +19.7% | 0.41% | -5.7% |
Q1 2021 | $20,717,000 | +359.5% | 1,159,309 | +247.3% | 0.44% | +334.7% |
Q4 2020 | $4,509,000 | +278.3% | 333,763 | +229.6% | 0.10% | +152.5% |
Q3 2020 | $1,192,000 | -51.2% | 101,249 | -38.8% | 0.04% | -54.5% |
Q2 2020 | $2,442,000 | +52.9% | 165,494 | +39.9% | 0.09% | +2.3% |
Q1 2020 | $1,597,000 | -73.2% | 118,278 | -52.0% | 0.09% | -68.6% |
Q4 2019 | $5,960,000 | +22.6% | 246,579 | -2.5% | 0.27% | +2.2% |
Q3 2019 | $4,862,000 | +224.6% | 252,942 | +399.0% | 0.27% | +262.2% |
Q2 2019 | $1,498,000 | -9.0% | 50,685 | +46.2% | 0.07% | -15.9% |
Q1 2019 | $1,647,000 | -20.5% | 34,676 | -39.6% | 0.09% | -40.1% |
Q4 2018 | $2,073,000 | – | 57,423 | – | 0.15% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 246,563 | $2,244,000 | 1.36% |
LEVIN CAPITAL STRATEGIES, L.P. | 1,435,876 | $13,066,000 | 1.26% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,695,020 | $42,725,000 | 0.96% |
DCF Advisers, LLC | 189,565 | $1,725,000 | 0.76% |
DAFNA Capital Management LLC | 289,040 | $2,630,000 | 0.68% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,678,609 | $15,275,000 | 0.61% |
Rhenman & Partners Asset Management AB | 589,200 | $5,362,000 | 0.53% |
PFM Health Sciences, LP | 1,088,566 | $9,906,000 | 0.37% |
NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $2,819,000 | 0.36% |
Granahan Investment Management | 1,588,944 | $14,459,000 | 0.36% |